19 Nov 2026, 09:01
Company Update—
Announcement history available from 1 August 2025
| Date / Time | Heading | Type | MS | Report Codes | |
|---|---|---|---|---|---|
| 19 Nov 2026, 09:01 | Lumos Secures Distribution for FebriDx in Portugal | Company Update | — | 11001 | |
| 13 Nov 2026, 14:09 | Results of Annual General Meeting | Meetings & Governance | — | 08003 | |
| 13 Nov 2026, 08:45 | 2026 AGM Presentation | Presentations | — | 03026 | |
| 13 Nov 2026, 08:42 | AGM Chair Address | Letters & Addresses | — | 15002 | |
| 9 Nov 2026, 08:31 | Lumos Expands FebriDx Adoption Across WellStreet Locations | Company Update | MS | 11001 | |
| 27 Oct 2026, 10:04 | Investor Presentation | Presentations | — | 03026 | |
| 27 Oct 2026, 09:59 | Quarterly Activities/Appendix 4C Cash Flow Report | Quarterly Reports | MS | 14014, 19001, 19006 | |
| 20 Oct 2026, 09:04 | Application for quotation of securities - LDX | Securities Administration | — | 06020 | |
| 19 Oct 2026, 11:28 | Q1 FY27 Quarterly Results Date & Webinar Invitation | Presentations | — | 03027, 14014 | |
| 13 Oct 2026, 14:43 | Final Director's Interest Notice - LM | Director Interests | — | 02010 | |
| 13 Oct 2026, 14:43 | Initial Director's Interest Notice - AS | Director Interests | — | 02008 | |
| 12 Oct 2026, 16:20 | Notice of Annual General Meeting and Proxy Form | Presentations | — | 08001, 08004, 14014 | |
| 12 Oct 2026, 11:32 | Lumos Diagnostics Board Changes | Company Administration | — | 12001 | |
| 9 Oct 2026, 09:40 | Notification of cessation of securities - LDX | Securities Administration | — | 06027 | |
| 30 Sept 2026, 09:16 | Section 708A Cleansing Statement | Securities Administration | — | 06018 | |
| 30 Sept 2026, 09:14 | Application for quotation of securities - LDX | Securities Administration | — | 06020 | |
| 15 Sept 2026, 16:40 | Change in substantial holding from RYD | Substantial Holders | — | 02002 | |
| 15 Sept 2026, 12:38 | Section 708A Cleansing Statement | Securities Administration | — | 06018 | |
| 15 Sept 2026, 12:37 | Application for quotation of securities - LDX | Securities Administration | — | 06020 | |
| 15 Sept 2026, 09:26 | FebriDx Commercial Traction Continues Across US Accounts | Company Update | MS | 11001 | |
| 1 Sept 2026, 13:50 | Section 708A Cleansing Statement | Securities Administration | — | 06018 | |
| 1 Sept 2026, 13:48 | Application for quotation of securities - LDX | Securities Administration | — | 06020 | |
| 1 Sept 2026, 13:04 | Change of Director's Interest Notice - DW | Director Interests | — | 02009 | |
| 26 Aug 2026, 10:06 | Appendix 4G and Corporate Governance Statement | Company Administration | — | 03024, 03025 | |
| 26 Aug 2026, 09:44 | FY26 Full Year Results Announcement | Financial Results | MS | 03003, 03014 | |
| 26 Aug 2026, 09:41 | FY26 Annual Report | Financial Results | — | 03001, 03002, 03011, 03012, 03013, 03020 | |
| 26 Aug 2026, 09:22 | FY26 Appendix 4E | Financial Results | MS | 03003 | |
| 7 Aug 2026, 11:02 | Lumos to Present at 20th Bioshares Biotech Summit | Presentations | — | 03026 | |
| 4 Aug 2026, 09:04 | Lumos Receives FebriDx Order from PHASE Scientific | Company Update | MS | 11001 | |
| 30 July 2026, 09:38 | Lumos Secures Distribution for FebriDx in Romania | Company Update | — | 11001 | |
| 28 July 2026, 12:42 | Change of Director's Interest Notice - DW | Director Interests | — | 02009 | |
| 28 July 2026, 09:40 | Section 708A Cleansing Statement | Securities Administration | — | 06018 | |
| 28 July 2026, 09:37 | Application for quotation of securities - LDX | Securities Administration | — | 06020 | |
| 27 July 2026, 12:01 | Investor Presentation | Presentations | — | 03026, 14014 | |
| 27 July 2026, 09:55 | Quarterly Activities/Appendix 4C Cash Flow Report | Quarterly Reports | MS | 14014, 19004, 19009 | |
| 21 July 2026, 12:08 | FebriDx Commercial Traction Across Priority US Accounts | Company Update | MS | 11001 | |
| 20 July 2026, 11:01 | Q4 FY26 Results Release Date and Webinar Invitation | Periodic Reports | — | 03027 | |
| 20 July 2026, 10:50 | Investor Information Sessions | Company Administration | — | 12008 | |
| 14 July 2026, 13:06 | Notification of cessation of securities - LDX | Securities Administration | — | 06027 | |
| 2 July 2026, 14:27 | Closure of A$5M Loan Facility with Major Shareholders | Capital Raising | — | 03022 | |
| 29 June 2026, 09:54 | Lumos Receives Research & Development Tax Rebate | Periodic Reports | MS | 03014 | |
| 25 June 2026, 11:48 | Change of Director's Interest Notice - SL | Director Interests | — | 02009 | |
| 22 June 2026, 12:12 | Application for quotation of securities - LDX | Securities Administration | — | 06020 | |
| 19 June 2026, 09:13 | Change of Director's Interest Notice - CR | Director Interests | — | 02009 | |
| 11 June 2026, 09:58 | Investor Presentation - FebriDx US Commercial Update | Presentations | — | 03026 | |
| 5 June 2026, 14:51 | Change of Director's Interest Notice - DW | Director Interests | — | 02009 | |
| 4 June 2026, 11:23 | FebriDx US Commercial Update Webinar Invitation | Presentations | — | 14014 | |
| 20 May 2026, 13:24 | Application for quotation of securities - LDX | Securities Administration | — | 06020 | |
| 20 May 2026, 13:24 | Section 708A Cleansing Statement | Securities Administration | — | 06018 | |
| 18 May 2026, 11:42 | FebriDx U.S. Rollout and Reimbursement Update - Amended | Company Update | MS | 11001 |